# Episode 420: Long-Term Myelodysplastic Syndrome Considerations for Oncology Nurses

Page: https://stenobird.com/podcast/the-ons-podcast-1126448/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses
Text version: https://stenobird.com/podcast/the-ons-podcast-1126448/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses.md
Podcast: [The ONS Podcast](https://stenobird.com/podcast/the-ons-podcast-1126448)
Published: 2026-06-19T07:00:00+00:00
Episode link: https://onsvoice.libsyn.com/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses
Audio file: https://traffic.libsyn.com/secure/onsvoice/420_Long_Term_MDS_Considerations_mixdown.mp3?dest-id=557038
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-ons-podcast-1126448/episodes/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses
Duration seconds: 2584

## Resource

"We typically think of the disease progressing for our higher-risk patients because many of them already start with increased blasts or a lot of dysplasia. And they have these chromosomal variants that make them prone to evolving into acute myeloid leukemia (AML). With them, we can anticipate that they are going to progress to AML. And that's what we're trying to prevent. It's kind of like a biologic evolution and not a switch," ONS member Sara Tinsley-Vance, PhD, APRN, AOCN ® , nurse practitioner and quality-of-life researcher at Moffitt Cancer Center in Tampa, FL, told Lenise Taylor, MN, RN, AOCNS ® , TCTCN ™ , oncology clinical specialist at ONS, during a conversation about long-term myelodysplastic syndrome (MDS) considerations for oncology nurses. Music Credit: " Fireflies and Stardust " by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 19, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to management of long-term side effects related to myelodysplastic syndrome and its treatment. Episode Notes Complete this evaluation for free NCPD . ONS Podcast ™ episodes: Episode 415: Myelodysplastic Syndrome Treatment Considerations for Oncology Nurses Episode 411: An Overview of Myelodysplastic Syndrome for Oncology Nurses Episode 256: Cancer Symptom Management Basics: Hematologic Complicatio…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-ons-podcast-1126448/episodes/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-ons-podcast-1126448/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.